Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
JEFFREY TATE Insider Profile
11 Followers
JEFFREY TATE, COO, Director at Cyclo Therapeutics, holds 92.04K shares in Cyclo Therapeutics (Ticker: CYTH). Most recently, JEFFREY TATE Bought $29,941 shares of Cyclo Therapeutics on Oct 23, 2023 for an estimated value of 21.26K.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
-15.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
COO, Director
Roles that JEFFREY TATE holds in companies
Most Profitable Insider Trade
The most profitable trade made by JEFFREY TATE
JEFFREY TATE's Trading History
List of latest transactions for each holding click on a transaction to see JEFFREY TATE's performance on stock
You May Also Like
JEFFREY TATE insider profile FAQ
What is the percentage of profitable transactions made by JEFFREY TATE?
The percentage of profitable transactions made by JEFFREY TATE is 40%.
What is the average return per transaction made by JEFFREY TATE?
The average return per transaction made by JEFFREY TATE is -15.70%.
What stocks does JEFFREY TATE hold?
JEFFREY TATE holds: CYTH stocks.
What was JEFFREY TATE’s latest transaction?
JEFFREY TATE latest transaction was an Informative Buy of $21.26K.
What was JEFFREY TATE's most profitable transaction?
JEFFREY TATE’s most profitable transaction was an Informative Buy of CYTH stock on April 24, 2023. The return on the trade was 62.50%.
What is JEFFREY TATE's role in Cyclo Therapeutics?
JEFFREY TATE's role in Cyclo Therapeutics is COO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.